Background and Objectives
Immunology is a critically important discipline. The immune system plays a fundamental role in a large number of major medical conditions as diverse as infections, allergy, autoimmune diseases, and cancer. Hence, as Singapore works to expand and strengthen the translational medical research capabilities, it was essential to strengthen the immunology research expertise.
The Singapore Immunology Network (SIgN) was initiated by A*STAR BMRC in December 2005 with the aim of building on the strengths of existing immunology research groups at A*STAR laboratories, universities and research hospitals, as well as expanding and strengthening the immunology research expertise in Singapore. It will also comprise new laboratories located in Biopolis.
Activities
The SIgN aims to:
Main Focus
Build up a strong platform in basic human immunology research for better translation into medical applications. In order to improve global understanding of the human immune system, emphasis would also be placed on systems biology approaches.
Support both national and international collaborations, particularly in the fields of cancer immunotherapy, autoimmune disorders, allergy, transplantation and infectious diseases.
Leadership
The SIgN is chaired by Prof Philippe Kourilsky, the Professor and Chair of Molecular Immunology at the College de France. He is a renowned expert in the field of Immunology and is also a member of Singapore's Biomedical Sciences International Advisory Council since 2000.
For more information on the Singapore Immunology Network (SIgN), please refer to http://www.sign.a-star.edu.sg.